| Watchers | 4,360 |
| 52-Wk Low | $3.43 |
| 52-Wk High | $23.50 |
| Market Cap | $3.45M |
| Volume | 7,000.00 |
| 52-Wk High | $23.50 |
| 52-Wk Low | $3.43 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Innovate Biopharmaceuticals, Inc. market cap is $3.45M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Innovate Biopharmaceuticals, Inc. 52 week high is $23.50 as of May 18, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Innovate Biopharmaceuticals, Inc. 52 week low is $3.43 as of May 18, 2024.
Innovate Biopharmaceuticals, Inc. stock price today is $0.60.
Innovate Biopharmaceuticals, Inc. stock price yesterday was $0.6101.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Innovate Biopharmaceuticals, Inc.’s P/E ratio is None.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Innovate Biopharmaceuticals, Inc. P/B ratio is -2.3178.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Innovate Biopharmaceuticals, Inc.'s EBITDA is N/A.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Innovate Biopharmaceuticals, Inc. 50-day moving average is $5.87.
Innovate Biopharmaceuticals, Inc. has 15 employees.